1031 related articles for article (PubMed ID: 21497433)
1. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
2. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review.
Alcaraz A; Hammerer P; Tubaro A; Schröder FH; Castro R
Eur Urol; 2009 Apr; 55(4):864-73. PubMed ID: 19027219
[TBL] [Abstract][Full Text] [Related]
3. The correlation between metabolic syndrome and prostatic diseases.
De Nunzio C; Aronson W; Freedland SJ; Giovannucci E; Parsons JK
Eur Urol; 2012 Mar; 61(3):560-70. PubMed ID: 22119157
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and chronic prostatic diseases: evidence for a link?
Sciarra A; Di Silverio F; Salciccia S; Autran Gomez AM; Gentilucci A; Gentile V
Eur Urol; 2007 Oct; 52(4):964-72. PubMed ID: 17618043
[TBL] [Abstract][Full Text] [Related]
5. [Inflammation and benign prostatic hyperplasia: cause or consequence?].
Robert G; Salagierski M; Schalken JA; de La Taille A
Prog Urol; 2010 Jun; 20(6):402-7. PubMed ID: 20538203
[TBL] [Abstract][Full Text] [Related]
6. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
Wang W; Bergh A; Damber JE
Prostate; 2009 Sep; 69(13):1378-86. PubMed ID: 19507201
[TBL] [Abstract][Full Text] [Related]
7. Correlation between benign prostatic hyperplasia and inflammation.
Bostanci Y; Kazzazi A; Momtahen S; Laze J; Djavan B
Curr Opin Urol; 2013 Jan; 23(1):5-10. PubMed ID: 23159991
[TBL] [Abstract][Full Text] [Related]
8. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
[TBL] [Abstract][Full Text] [Related]
9. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
[TBL] [Abstract][Full Text] [Related]
10. A unifying hypothesis that links benign prostatic hyperplasia and prostatic intraepithelial neoplasia with prostate cancer. Invited comments.
Harvey H
Pathol Res Pract; 1995 Sep; 191(9):924-34. PubMed ID: 8606875
[TBL] [Abstract][Full Text] [Related]
11. Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.
Abdel-Meguid TA; Mosli HA; Al-Maghrabi JA
Saudi Med J; 2009 Dec; 30(12):1563-7. PubMed ID: 19936421
[TBL] [Abstract][Full Text] [Related]
12. Prostate growth and inflammation.
Sciarra A; Mariotti G; Salciccia S; Autran Gomez A; Monti S; Toscano V; Di Silverio F
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):254-60. PubMed ID: 17935971
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia.
Fibbi B; Penna G; Morelli A; Adorini L; Maggi M
Int J Androl; 2010 Jun; 33(3):475-88. PubMed ID: 19508330
[TBL] [Abstract][Full Text] [Related]
14. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
15. [Early histopathological aspects of benign prostatic hyperplasia: myxoid-inflammatory nodules].
Manzarbeitia F; Vela Navarrete R; Fernández-Aceñero MJ
Actas Urol Esp; 2010 Jun; 34(6):549-54. PubMed ID: 20510119
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammation in benign prostatic hyperplasia: implications for therapy.
Wang L; Yang JR; Yang LY; Liu ZT
Med Hypotheses; 2008; 70(5):1021-3. PubMed ID: 17935901
[TBL] [Abstract][Full Text] [Related]
17. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Kramer G; Mitteregger D; Marberger M
Eur Urol; 2007 May; 51(5):1202-16. PubMed ID: 17182170
[TBL] [Abstract][Full Text] [Related]
18. Could inflammation be a key component in the progression of benign prostatic hyperplasia?
Kramer G; Marberger M
Curr Opin Urol; 2006 Jan; 16(1):25-9. PubMed ID: 16385197
[TBL] [Abstract][Full Text] [Related]
19. The role of prostatic inflammation in the development and progression of benign and malignant diseases.
Gandaglia G; Zaffuto E; Fossati N; Cucchiara V; Mirone V; Montorsi F; Briganti A
Curr Opin Urol; 2017 Mar; 27(2):99-106. PubMed ID: 27906778
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]